Welcome to our dedicated page for Pathfinder Bancorp Md SEC filings (Ticker: PBHC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Looking for the numbers behind Pathfinder Bancorp’s community-bank success? Most investors start with the 10-K, but navigating hundreds of pages is time-consuming. Our filings hub answers the exact questions people ask—“Where is the Pathfinder Bancorp annual report 10-K simplified?” or “How do I track Pathfinder Bancorp insider trading Form 4 transactions?”—and delivers the documents instantly.
Begin your review with AI-generated highlights that break down loan-portfolio quality, deposit growth and interest-rate exposure. Whether you need the latest Pathfinder Bancorp quarterly earnings report 10-Q filing or a concise brief on a surprise Pathfinder Bancorp 8-K material events explained, Stock Titan’s engine surfaces the right section and explains it in plain language. You’ll also find Pathfinder Bancorp Form 4 insider transactions real-time, letting you see executive buying or selling the moment it hits EDGAR.
Our coverage spans every form: the proxy statement for Pathfinder Bancorp executive compensation, call-out tables that clarify risk-weighted assets, and alerts for Pathfinder Bancorp executive stock transactions Form 4. Use AI to compare quarters, export data, and share insights—perfect for anyone understanding Pathfinder Bancorp SEC documents with AI or needing a quick Pathfinder Bancorp earnings report filing analysis. All filings are updated in real time, so you’ll never miss a disclosure.
SCYNEXIS, Inc. (SCYX) – Form 4 insider transaction
Non-employee director Armando Anido reported two equity awards granted on 26 June 2025:
- 23,000 restricted stock units (RSUs) of common stock at a deemed price of $0 (code “A”). All RSUs vest 100 % on the first anniversary of the grant, contingent on continued board service. Post-grant, Anido holds 71,000 directly owned shares.
- Stock option for 23,000 shares with an exercise price of $0.74, expiring 25 June 2035. The option also vests 100 % after one year of service.
The filing signals additional equity-based alignment between the director and shareholders but represents a routine non-cash compensation grant rather than an open-market purchase. No sale or disposition occurred, and no immediate cash outflow by the company is disclosed. The total potential dilution from the awards is immaterial relative to SCYNEXIS’s outstanding share count.